L’Associaci\u00f3 Espanyola Contra el C\u00e0ncer ha celebrat un acte a Barcelona amb motiu de la presentaci\u00f3 dels nous projectes de recerca en c\u00e0ncer 2023. En total, a tot l\u2019Estat s\u2019han atorgat 29,4 M\u20ac en 233 ajudes. D\u2019aquestes, 44 han estat destinades a Barcelona, dues de les quals a l’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL).<\/p>\n
Les adjudicacions han estat condu\u00efdes pel Dr. Laureano Molins, president de l’Associaci\u00f3 Espanyola Contra el C\u00e0ncer de Barcelona, i la Dra. Marta Puyol, directora cient\u00edfica de la Fundaci\u00f3 Cient\u00edfica de l’Associaci\u00f3. Tamb\u00e9 s\u2019han celebrat dues taules de di\u00e0leg amb la participaci\u00f3 d\u2019alguns dels investigadors beneficiaris dels ajuts i tamb\u00e9 de pacients per parlar de la translacionalitat de la recerca oncol\u00f2gica. L\u2019acte ha finalitzat amb el testimoni d\u2019una pacient.<\/p>\n
A l\u2019IDIBELL, gr\u00e0cies a una ajuda LAB, l\u2019equip liderat per la Dra B\u00e1rbara Rivera<\/strong> investigar\u00e0 dos s\u00edndromes associats amb la predisposici\u00f3 al c\u00e0ncer per aix\u00ed identificar miRNAs que actuin com a biomarcadors de diagn\u00f2stic i pron\u00f2stic i tamb\u00e9 possibles estrat\u00e8gies de tractament. Per altra banda, la Dra Marta Crous, <\/strong>investigadora de l’ICO (Programa de recerca en epidemiologia del c\u00e0ncer) i de l’IDIBELL, rebr\u00e0 una ajuda Proyectos Estrat\u00e9gicos per estudiar com influeix l\u2019estil de vida, principalment l\u2019alimentaci\u00f3 i l\u2019exercici f\u00edsic, en el risc i la superviv\u00e8ncia del c\u00e0ncer d\u2019endometri. A part, les estudiants Emma Gonzalvez i Laura Ros han rebut una ajuda per fer l\u2019estada de pr\u00e0ctiques acad\u00e8miques a l\u2019IDIBELL.<\/p>\n Els ajuts en Recerca de l’Associaci\u00f3 adjudicats cobreixen totes les fases de la carrera investigadora i totes les fases de la investigaci\u00f3, des de la investigaci\u00f3 b\u00e0sica fins a la innovaci\u00f3 i la investigaci\u00f3 cl\u00ednica, a m\u00e9s de tots els tipus de c\u00e0ncers.<\/p>\n <\/p>\n <\/p>\n L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" Dos projectes de l\u2019IDIBELL, un liderat per la Dra Marta Crous i l\u2019altre per la Dra B\u00e1rbara Rivera, han estat seleccionats per rebre finan\u00e7ament de l\u2019Associaci\u00f3 Contra el C\u00e0ncer.<\/p>\n","protected":false},"author":8,"featured_media":25192,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[332,417,369,454,447],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-20 09:23:37","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25188"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=25188"}],"version-history":[{"count":5,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25188\/revisions"}],"predecessor-version":[{"id":25196,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25188\/revisions\/25196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/25192"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=25188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=25188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=25188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}